Thomas Gidoin Joins OSE Immunotherapeutics as Chief Financial Officer
August 20, 2025 - 23:13
NANTES, France, August 20, 2025 – OSE Immunotherapeutics SA has officially announced the appointment of Thomas Gidoin as its new Chief Financial Officer. With over 15 years of extensive experience in capital markets and financial strategy, Gidoin brings a wealth of knowledge and expertise to the company’s Executive Committee.
Gidoin's background in biopharma finance is marked by a strong track record in strategic financial leadership, which he has demonstrated in both private and public sectors. His appointment is anticipated to enhance OSE Immunotherapeutics' financial governance and strategic initiatives, positioning the company for future growth and success.
The addition of Gidoin to the leadership team is seen as a pivotal move to strengthen the company's financial operations and align its strategies with the evolving landscape of the biopharmaceutical industry. Stakeholders and investors alike are looking forward to the insights and direction he will bring in his new role.
MORE NEWS
November 21, 2025 - 13:14
Retail Expert Predicts Price Increases Due to Tariffs in 2026As we look beyond the 2025 holiday shopping season, retail expert Lauren Murphy forecasts significant price increases for consumer goods in 2026, primarily driven by tariffs. Murphy, who serves as...
November 20, 2025 - 20:47
Trump Nominates Stuart Levenbach as Director of CFPBPresident Trump has put forward the nomination of Stuart Levenbach, currently serving as an Associate Director of the Office of Management and Budget (OMB), to lead the Consumer Financial...
November 20, 2025 - 05:57
Divided Opinions Among Fed Officials on December Rate CutsFed officials are divided over whether to cut interest rates again in December, according to minutes from the central bank’s last policy meeting. The discussions revealed a spectrum of opinions...
November 19, 2025 - 00:52
Understanding the New Normal: A 5% Mortgage Rate in the Housing MarketAs the housing market continues to evolve, industry experts are emphasizing the significance of a 5% mortgage rate as the new standard. Jim Tobin, CEO of the National Association of Home Builders,...